Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 31Terminated 9Recruiting 5Withdrawn 4Active not recruiting 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2

Conditions

Urinary Bladder Neoplasms 2Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 35Cisplatin 24fludarabine 23Radiotherapy 23Paclitaxel 21Carboplatin 20pembrolizumab 18Nivolumab 18Magnetic Resonance Spectroscopy 18Specimen Handling 17fludarabine phosphate 15Gemcitabine 15Biopsy 15Cytarabine 14Radiation 11Filgrastim 11Doxorubicin 11Docetaxel 11Dexamethasone 11Radiosurgery 10Granulocyte Colony-Stimulating Factor 10Etoposide 10Melphalan 9Ipilimumab 9venetoclax 8Rituximab 8Calcium Dobesilate 8trametinib 7ibrutinib 7durvalumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Withdrawn × tremelimumab × Clear all
NCT03802747 2024-12-09

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

University of Colorado, Denver

Phase 1 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT04073160 2020-07-07

TRIO Bladder

Duke University

Phase 1 Withdrawn
Genitourinary

Urinary Bladder Neoplasms

NCT00880854 2019-11-15

Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

University of Wisconsin, Madison

Phase 1 Withdrawn
Genitourinary

Urinary Bladder Neoplasms

NCT02868632 2019-04-05

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

NYU Langone Health

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡